Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
P/E ratio for Olympus Corporation (7733.T)
P/E ratio as of 2023: 10.93
According to Olympus Corporation's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 10.93. At the end of 2022 the company had a P/E ratio of 20.48.
P/E ratio history for Olympus Corporation from 1999 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 10.93 |
| 2022 | 20.48 |
| 2021 | 25.93 |
| 2020 | 228.00 |
| 2019 | 39.67 |
| 2018 | 203.16 |
| 2017 | 24.21 |
| 2016 | 18.73 |
| 2015 | 23.92 |
| 2014 | -174.90 |
| 2013 | 80.15 |
| 2012 | 80.46 |
| 2011 | -8.33 |
| 2010 | 94.44 |
| 2009 | 18.92 |
| 2008 | -4.15 |
| 2007 | 15.69 |
| 2006 | 25.40 |
| 2005 | 36.49 |
| 2004 | -63.68 |
| 2003 | 20.10 |
| 2002 | 23.22 |
| 2001 | 48.48 |
| 2000 | 46.97 |
| 1999 | 262.81 |